1. The Potential Role of Antisense Oligodeoxynucleotide Therapy for Cardiovascular Disease

   • M. Ian Phillips
   • Sara M. Galli
   • Jawahar L. Mehta

   Leading Article 17 September 2012 Pages: 239 - 248

2. Viral Vectors for Gene Transfer

   • Wolfgang Walther
   • Ulrike Stein

   Review Article 17 September 2012 Pages: 249 - 271

3. Potential Novel Uses of Thalidomide

   • Vera Peuckmann
   • Michael Fisch
   • Eduardo Bruera

   Review Article 17 September 2012 Pages: 273 - 292

4. A Review of the Long Term Effects of Thrombolytic Agents

   • Ron T. van Domburg
   • Eric Boersma
   • Maarten L. Simoons

   Review Article 17 September 2012 Pages: 293 - 305

5. Long-Acting β₂ Agonists in the Management of Stable Chronic Obstructive Pulmonary Disease

   • Mario Cazzola
   • Claudio Ferdinando Donner

   Disease Management 17 September 2012 Pages: 307 - 320

6. Esomeprazole

   • Caroline M. Spencer
   • Diana Faulds

   Adis New Drug Profile 17 September 2012 Pages: 321 - 329

   

7. Esomeprazole

   • Peter Katelaris

   Adis New Drug Profile 17 September 2012 Pages: 330 - 330

8. Esomeprazole

   • Tore Lind

   Adis New Drug Profile 17 September 2012 Pages: 330 - 331

9. Pioglitazone

   • Peter S. Gillies
   • Christopher J. Dunn

   Adis New Drug Profile 17 September 2012 Pages: 333 - 343

10. Pioglitazone

    • John R. Petrie

    Adis New Drug Profile 17 September 2012 Pages: 344 - 344

11. Pioglitazone

    • Vivian A. Fonseca

    Adis New Drug Profile 17 September 2012 Pages: 344 - 345

12. Clopidogrel

    • Blair Jarvis
    • Kerryn Simpson

    Adis Drug Evaluation 17 September 2012 Pages: 347 - 377

13. Raloxifene

    • Delyth Clemett
    • Caroline M. Spencer

    Adis Drug Evaluation 17 September 2012 Pages: 379 - 411

14. Zaleplon

    • Mukta Dooley
    • Greg L. Plosker

    Adis Drug Evaluation 17 September 2012 Pages: 413 - 445

15. Abacavir

    • Pauline S. Hervey
    • Caroline M. Perry

    Adis Drug Evaluation 17 September 2012 Pages: 447 - 479

16. Saquinavir Soft-Gel Capsule

    • David P. Figgitt
    • Greg L. Plosker

    Adis Drug Evaluation 17 September 2012 Pages: 481 - 516